Pulling SEC filings + quote and writing the call…

Sunrun Inc.
Next earnings Aug 4, 2026 (after close) · consensus $0.25 EPS, $766M rev
Last earnings -4.7% on 2026-05-06
Headline P/E of 8.4x masks a still-cash-burning, $14.7B-debt business reliant on tax equity and policy tailwinds — the 'earnings' aren't cash.
Revenue $2.96B · FY2025
It screens cheap (~401% below fair value), but the weak fundamentals are why — more potential value trap than bargain.
The 8.4x P/E on $1.71 diluted EPS looks like a steal until you reconcile it to the rest of the statement: operating income was still **-$126M** in FY2025 and operating cash flow was **-$421M**. The $450M of net income is accounting profit, not cash — Sunrun's business model is to monetize Commercial ITCs, accelerated depreciation and tax-equity fund cash flows, and the 10-K explicitly frames the financial structure around 'non-recourse project financings' and tax-equity funds. Strip those and the underlying solar-services business is still operating at a loss. The +115.8% net income swing off a -$2.85B FY2024 base is more about prior impairment math than a durable inflection.
The balance sheet is the bigger issue. Long-term debt of **$14.7B** against $3.13B of equity (5.63x L/E) and -$3.83B of accumulated deficit makes this a leveraged project-finance shell more than a typical operating company. Management openly states it 'will continue to be dependent on financing from outside parties' and disclosed a $2.0B PV-module/inverter/battery purchase commitment plus a February 2024 issuance of $475M of converts maturing March 2030. FY2025 needed **$3.2B in financing inflows** (vs. $2.5B used in investing) just to fund the asset roll-out — that machine only works while capital is cheap and the ITC framework holds.
Is RUN a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.61B | $2.32B | $2.26B | $2.04B | $2.96B |
| Gross profit | — | — | — | — | — |
| Operating income | -$666M | -$662M | -$1.98B | -$3.70B | -$126M |
| Net income | -$79.4M | $173M | -$1.60B | -$2.85B | $450M |
| Diluted EPS | -$0.39 | $0.80 | -$7.41 | -$12.81 | $1.71 |
| Net margin | -4.9% | 7.5% | -71.0% | -139.7% | 15.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine governance with no strategic shift.
Q1 2026 10-Q details ongoing positive NI trend and continued tax-equity financing reliance.
Q1 2026 10-Q details ongoing positive NI trend and continued tax-equity financing reliance.
2026 proxy: routine board slate and exec comp; no governance red flags.
FY25 10-K: profitable year, $1B available capital, but op CF still -$421M and 5.6x lev.
FY25 10-K: profitable year, $1B available capital, but op CF still -$421M and 5.6x lev.
New material financing agreement adds direct debt obligation to fund deployments.
Q3 2025 10-Q shows revenue acceleration en route to FY25 recovery.
Q3 2025 10-Q shows revenue acceleration en route to FY25 recovery.
Sources: SEC EDGAR (CIK 0001469367, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/25/2026, 1:10:57 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:10 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 5 sales
| 2026-07-01 | Jurich Lynn Michelle Director | Award | 8.31K | |
| 2026-07-01 | Fenster Edward Harris Director | Award | 8.31K | |
| 2026-07-01 | Jurich Lynn Michelle Director | Sell | 50.0K @ $13.61 | $680K |
| 2026-06-11 | Lontoh Sonita Director | Sell | 7.50K @ $12.00 | $90.0K |
| 2026-06-08 | Abajian Danny Chief Financial Officer | Sell | 2.03K @ $13.39 | $27.2K |
| 2026-06-08 | Abajian Danny Chief Financial Officer | Gift | 1.97K | |
| 2026-06-08 | Abajian Danny Chief Financial Officer | Gift | 1.97K | |
| 2026-06-01 | Jurich Lynn Michelle Director | Sell | 50.0K @ $15.92 | $796K |
| 2026-05-01 | Jurich Lynn Michelle Director | Sell | 50.0K @ $12.89 | $645K |
| 2026-04-10 | STEELE JEANNA Chief Legal & People Officer | Award | 87.1K |
| Two Sigma Investments | 7.79M sh | $106M |
| D. E. Shaw & Co. | 7.26M sh | $98.5M |
| Soros Fund Management | 19.5K sh | $264K |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median